
Next-generation sequencing (NGS) has enabled us to extract genetic information from samples faster, more reliably, and at lower cost than ever before. Getting your DNA ready for sequencing requires the preparation of a sequencing library as well as a few other steps that depend on the type of sample and the NGS platform.These steps include DNA extraction, amplification, library preparation, selection or purification, and quality control.
The global market for Next Generation Sequencing Sample Preparation was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Next Generation Sequencing Sample Preparation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next Generation Sequencing Sample Preparation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Next Generation Sequencing Sample Preparation was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Next Generation Sequencing Sample Preparation include Agilent Technologies, Myriad Genetics, Oxford Nanopore Technologies, Foundation Medicine, Genomatix GmbH, Illumina, Pacific Biosciences of California, Partek Incorporated and Perkin Elmer, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing Sample Preparation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next Generation Sequencing Sample Preparation by region & country, by Type, and by Application.
The Next Generation Sequencing Sample Preparation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing Sample Preparation.
Market Segmentation
By Company
Agilent Technologies
Myriad Genetics
Oxford Nanopore Technologies
Foundation Medicine
Genomatix GmbH
Illumina
Pacific Biosciences of California
Partek Incorporated
Perkin Elmer
PierianDx
QIAGEN
Quest Diagnostics Incorporated
Thermo Fisher Scientific
Congenica
DNASTAR
Eurofins Scientific
Roche
BGI
Bio-Rad Laboratories
Macrogen
Segment by Type:
NGS Library Preparation Kits
Semi-Automated Library Preparation
Automated Library Preparation
Clonal Amplification
Segment by Application
Oncology
Clinical Investigation
Reproductive Health
HLA Typing/Immune System Monitoring
Metagenomics
Agrigenomics & Forensics
Consumer Genomics
Epidemiology & Drug Development
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Next Generation Sequencing Sample Preparation manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Next Generation Sequencing Sample Preparation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Next Generation Sequencing Sample Preparation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Next Generation Sequencing Sample Preparation Product Introduction
1.2 Global Next Generation Sequencing Sample Preparation Market Size Forecast
1.3 Next Generation Sequencing Sample Preparation Market Trends & Drivers
1.3.1 Next Generation Sequencing Sample Preparation Industry Trends
1.3.2 Next Generation Sequencing Sample Preparation Market Drivers & Opportunity
1.3.3 Next Generation Sequencing Sample Preparation Market Challenges
1.3.4 Next Generation Sequencing Sample Preparation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Next Generation Sequencing Sample Preparation Players Revenue Ranking (2023)
2.2 Global Next Generation Sequencing Sample Preparation Revenue by Company (2019-2024)
2.3 Key Companies Next Generation Sequencing Sample Preparation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Next Generation Sequencing Sample Preparation Product Offered
2.5 Key Companies Time to Begin Mass Production of Next Generation Sequencing Sample Preparation
2.6 Next Generation Sequencing Sample Preparation Market Competitive Analysis
2.6.1 Next Generation Sequencing Sample Preparation Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Next Generation Sequencing Sample Preparation Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing Sample Preparation as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NGS Library Preparation Kits
3.1.2 Semi-Automated Library Preparation
3.1.3 Automated Library Preparation
3.1.4 Clonal Amplification
3.2 Global Next Generation Sequencing Sample Preparation Sales Value by Type
3.2.1 Global Next Generation Sequencing Sample Preparation Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Next Generation Sequencing Sample Preparation Sales Value, by Type (2019-2030)
3.2.3 Global Next Generation Sequencing Sample Preparation Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Clinical Investigation
4.1.3 Reproductive Health
4.1.4 HLA Typing/Immune System Monitoring
4.1.5 Metagenomics
4.1.6 Agrigenomics & Forensics
4.1.7 Consumer Genomics
4.1.8 Epidemiology & Drug Development
4.2 Global Next Generation Sequencing Sample Preparation Sales Value by Application
4.2.1 Global Next Generation Sequencing Sample Preparation Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Next Generation Sequencing Sample Preparation Sales Value, by Application (2019-2030)
4.2.3 Global Next Generation Sequencing Sample Preparation Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Next Generation Sequencing Sample Preparation Sales Value by Region
5.1.1 Global Next Generation Sequencing Sample Preparation Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Next Generation Sequencing Sample Preparation Sales Value by Region (2019-2024)
5.1.3 Global Next Generation Sequencing Sample Preparation Sales Value by Region (2025-2030)
5.1.4 Global Next Generation Sequencing Sample Preparation Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
5.2.2 North America Next Generation Sequencing Sample Preparation Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
5.3.2 Europe Next Generation Sequencing Sample Preparation Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
5.4.2 Asia Pacific Next Generation Sequencing Sample Preparation Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
5.5.2 South America Next Generation Sequencing Sample Preparation Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
5.6.2 Middle East & Africa Next Generation Sequencing Sample Preparation Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Next Generation Sequencing Sample Preparation Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Next Generation Sequencing Sample Preparation Sales Value
6.3 United States
6.3.1 United States Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
6.3.2 United States Next Generation Sequencing Sample Preparation Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Next Generation Sequencing Sample Preparation Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
6.4.2 Europe Next Generation Sequencing Sample Preparation Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Next Generation Sequencing Sample Preparation Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
6.5.2 China Next Generation Sequencing Sample Preparation Sales Value by Type (%), 2023 VS 2030
6.5.3 China Next Generation Sequencing Sample Preparation Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
6.6.2 Japan Next Generation Sequencing Sample Preparation Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Next Generation Sequencing Sample Preparation Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
6.7.2 South Korea Next Generation Sequencing Sample Preparation Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Next Generation Sequencing Sample Preparation Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
6.8.2 Southeast Asia Next Generation Sequencing Sample Preparation Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Next Generation Sequencing Sample Preparation Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Next Generation Sequencing Sample Preparation Sales Value, 2019-2030
6.9.2 India Next Generation Sequencing Sample Preparation Sales Value by Type (%), 2023 VS 2030
6.9.3 India Next Generation Sequencing Sample Preparation Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Profile
7.1.2 Agilent Technologies Main Business
7.1.3 Agilent Technologies Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.1.4 Agilent Technologies Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.1.5 Agilent Technologies Recent Developments
7.2 Myriad Genetics
7.2.1 Myriad Genetics Profile
7.2.2 Myriad Genetics Main Business
7.2.3 Myriad Genetics Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.2.4 Myriad Genetics Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.2.5 Myriad Genetics Recent Developments
7.3 Oxford Nanopore Technologies
7.3.1 Oxford Nanopore Technologies Profile
7.3.2 Oxford Nanopore Technologies Main Business
7.3.3 Oxford Nanopore Technologies Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.3.4 Oxford Nanopore Technologies Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.3.5 Foundation Medicine Recent Developments
7.4 Foundation Medicine
7.4.1 Foundation Medicine Profile
7.4.2 Foundation Medicine Main Business
7.4.3 Foundation Medicine Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.4.4 Foundation Medicine Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.4.5 Foundation Medicine Recent Developments
7.5 Genomatix GmbH
7.5.1 Genomatix GmbH Profile
7.5.2 Genomatix GmbH Main Business
7.5.3 Genomatix GmbH Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.5.4 Genomatix GmbH Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.5.5 Genomatix GmbH Recent Developments
7.6 Illumina
7.6.1 Illumina Profile
7.6.2 Illumina Main Business
7.6.3 Illumina Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.6.4 Illumina Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.6.5 Illumina Recent Developments
7.7 Pacific Biosciences of California
7.7.1 Pacific Biosciences of California Profile
7.7.2 Pacific Biosciences of California Main Business
7.7.3 Pacific Biosciences of California Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.7.4 Pacific Biosciences of California Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.7.5 Pacific Biosciences of California Recent Developments
7.8 Partek Incorporated
7.8.1 Partek Incorporated Profile
7.8.2 Partek Incorporated Main Business
7.8.3 Partek Incorporated Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.8.4 Partek Incorporated Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.8.5 Partek Incorporated Recent Developments
7.9 Perkin Elmer
7.9.1 Perkin Elmer Profile
7.9.2 Perkin Elmer Main Business
7.9.3 Perkin Elmer Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.9.4 Perkin Elmer Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.9.5 Perkin Elmer Recent Developments
7.10 PierianDx
7.10.1 PierianDx Profile
7.10.2 PierianDx Main Business
7.10.3 PierianDx Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.10.4 PierianDx Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.10.5 PierianDx Recent Developments
7.11 QIAGEN
7.11.1 QIAGEN Profile
7.11.2 QIAGEN Main Business
7.11.3 QIAGEN Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.11.4 QIAGEN Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.11.5 QIAGEN Recent Developments
7.12 Quest Diagnostics Incorporated
7.12.1 Quest Diagnostics Incorporated Profile
7.12.2 Quest Diagnostics Incorporated Main Business
7.12.3 Quest Diagnostics Incorporated Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.12.4 Quest Diagnostics Incorporated Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.12.5 Quest Diagnostics Incorporated Recent Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Profile
7.13.2 Thermo Fisher Scientific Main Business
7.13.3 Thermo Fisher Scientific Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.13.4 Thermo Fisher Scientific Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.13.5 Thermo Fisher Scientific Recent Developments
7.14 Congenica
7.14.1 Congenica Profile
7.14.2 Congenica Main Business
7.14.3 Congenica Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.14.4 Congenica Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.14.5 Congenica Recent Developments
7.15 DNASTAR
7.15.1 DNASTAR Profile
7.15.2 DNASTAR Main Business
7.15.3 DNASTAR Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.15.4 DNASTAR Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.15.5 DNASTAR Recent Developments
7.16 Eurofins Scientific
7.16.1 Eurofins Scientific Profile
7.16.2 Eurofins Scientific Main Business
7.16.3 Eurofins Scientific Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.16.4 Eurofins Scientific Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.16.5 Eurofins Scientific Recent Developments
7.17 Roche
7.17.1 Roche Profile
7.17.2 Roche Main Business
7.17.3 Roche Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.17.4 Roche Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.17.5 Roche Recent Developments
7.18 BGI
7.18.1 BGI Profile
7.18.2 BGI Main Business
7.18.3 BGI Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.18.4 BGI Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.18.5 BGI Recent Developments
7.19 Bio-Rad Laboratories
7.19.1 Bio-Rad Laboratories Profile
7.19.2 Bio-Rad Laboratories Main Business
7.19.3 Bio-Rad Laboratories Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.19.4 Bio-Rad Laboratories Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.19.5 Bio-Rad Laboratories Recent Developments
7.20 Macrogen
7.20.1 Macrogen Profile
7.20.2 Macrogen Main Business
7.20.3 Macrogen Next Generation Sequencing Sample Preparation Products, Services and Solutions
7.20.4 Macrogen Next Generation Sequencing Sample Preparation Revenue (US$ Million) & (2019-2024)
7.20.5 Macrogen Recent Developments
8 Industry Chain Analysis
8.1 Next Generation Sequencing Sample Preparation Industrial Chain
8.2 Next Generation Sequencing Sample Preparation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Next Generation Sequencing Sample Preparation Sales Model
8.5.2 Sales Channel
8.5.3 Next Generation Sequencing Sample Preparation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Agilent Technologies
Myriad Genetics
Oxford Nanopore Technologies
Foundation Medicine
Genomatix GmbH
Illumina
Pacific Biosciences of California
Partek Incorporated
Perkin Elmer
PierianDx
QIAGEN
Quest Diagnostics Incorporated
Thermo Fisher Scientific
Congenica
DNASTAR
Eurofins Scientific
Roche
BGI
Bio-Rad Laboratories
Macrogen
Ìý
Ìý
*If Applicable.
